Jefferson Health

Physician Profile

Charles Yeo, MD, FACS

Jefferson University Physician

Academic Title: Professor
Samuel D. Gross Professor of Surgery
Chair, Department of Surgery
Co-Director, Pancreas, Biliary and Related Cancer Center

Specialties
Surgery
Surgery - Alimentary Tract
Surgery - Hepato-Pancreatic-Biliary
Surgery - Oncology

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

Philadelphia
1100 Walnut Street
5th Floor
Philadelphia PA 19107
Phone: (215) 955-9402
Fax: (215) 923-6609

Medical Services

Years in Practice

31

Board Certifications

  • Surgery

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital
  • Methodist Hospital Division of Thomas Jefferson University Hospital

Awards and Honors

Philadelphia Magazine's Top Docs 2016,2015,2014,2013,2012,2011,2010,2009

Castle Connolly's America's Top Doctors 2014,2013,2012,2011,2010,2009,2008,2007

Castle Connolly's America's Top Doctors for Cancer 2014,2013,2012,2011,2010

Notes

Dr. Yeo completed an advanced GI surgery and vascular surgery fellowship at Johns Hopkins University Hospital. Dr. Yeo received his undergraduate degree at Princeton University.

Education

  • Johns Hopkins University School of Medicine, Medical School

Internship

  • Johns Hopkins University Hospital

Residency

  • Johns Hopkins University Hospital

Fellowship

  • Johns Hopkins University Hospital
  • SUNY Downstate Medical Center - Brooklyn

Recent Publications

WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner

Invited Commentary: Pasireotide and the Prevention of Pancreatic Fistula After Pancreatectomy: “The Continued Search for Harry Potterʼs Liquid Luck”

Modified Appleby Procedure with Arterial Reconstruction for Locally Advanced Pancreatic Adenocarcinoma: A Literature Review and Report of Three Unusual Cases

Hypothyroidism in Pancreatic Cancer: Role of Exogenous Thyroid Hormone in Tumor Invasion - Preliminary Observations

Recurrence and survival after resection of small intraductal papillary mucinous neoplasm-associated Carcinomas (≤ 20-mm invasive component) A multi-institutional analysis

HuR contributes to TRAIL resistance by restricting death receptor 4 expression in pancreatic cancer cells

Delayed Gastric Emptying After Pancreaticoduodenectomy: an Analysis of Risk Factors and Cost

Fluid Restriction During Pancreaticoduodenectomy. Is It Effective in Reducing Postoperative Complications?

Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- And tissue-specific microRNAs

Cancer of the pancreas

Pancreatic ductal adenocarcinoma treatment - The past, present, and future

Francis Daniels moore: One of the brightest minds in the surgical field

Evaluation of the validity of medical students' self-assessments of proficiency in clinical simulations

Dr. Mary Edwards Walker: years ahead of her time

The influence of transection site on the development of pancreatic fistula in patients undergoing distal pancreatectomy: A review of 294 consecutive cases

Minimally invasive esophagectomy provides significant survival advantage compared with open or hybrid esophagectomy for patients with cancers of the esophagus and gastroesophageal junction

Osteopontin (OPN) Isoforms, Diabetes, Obesity, and Cancer; What Is One Got to Do with the Other? A New Role for OPN

Incidence and Severity of Pancreatogenic Diabetes After Pancreatic Resection

A prospective, randomized, double-blind, placebo controlled trial on the efficacy of ethanol celiac plexus neurolysis in patients with operable pancreatic and periampullary adenocarcinoma